Surgical Sealants and Adhesives Market is segmented by Product (Natural (Fibrin, Collagen, Gelatin), Syn2thetic (Hydrogel)), Indication (Tissue Sealing, Tissue Engineering), Application (CNS, Cardiovascular, Cosmetic Surgery), End User (Hospital, Clinics and other players)
Surgical sealants and adhesives market is projected to reach USD 2.78 billion in 2028 from USD 1.9 billion in 2020 at 8.4% CAGR.
Surgical sealants and adhesives can be potentially used in replacing sutures and staples for closure with minimal blood loss, faster implementation and less painful for patients undergoing operation without the need for removal. These can also prevent air and liquid leakages so it is an added security in making sure complications during operations are avoided.
Growth of Market
The growth is driven by factors such as the increase and prevalence of a number of disorders such as obesity and CVDs; rate of trauma patients; number of injuries related to accidents and sports which in turn, spike the demand for surgical procedures performed globally. Managing blood loss from patients is also one concern that needs to be controlled and the the innovation to come up with products in research and development triggers the growth of this market. Outcomes from successful cosmetic procedures also increase the demand for surgical sealants and adhesives. Another attractive growth opportunity is the prominent use of the adhesives and sealants in the field of dentistry.
Challenges in the Market
A restraint is the negative impact brought upon by the pandemic because of the lock downs and implemented protocols which may have disrupted the supply chain, distribution and manufacturing in facilities of prominent companies. This can be considered a big set back in the growth of the diagnostic devices market because if manufacturing and distribution of products are affected, production and sales will also be negatively affected making it for challenging for these companies to meet demands of end users--surgical operations are commonly delayed, if not, postponed.
Market Key Findings
Surgical Sealants and adhesives market is segmented into: natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives.
The largest share accounted for in 2020 is the natural/biological sealants and adhesives because sealants coming from natural polymers has superior compatibility than other materials, has a reduced immune response, and an in vivo degradability than other sealants. This means that it is efficient and an effective way to repair injured tissues and strengthen closed surgical wounds, therefore replacing the usual suturing techniques.
Based on indication segment, it is further classified into tissue sealing, surgical hemostasis, and tissue engineering. On the other hand, tissue engineering segment is expected to have the highest growth in the market during the forecast period. This segment is in demand because of the increasing need for tissue regenerating procedures in cases of skin or burn injuries together with the high rise of cosmetic surgeries taking place in regions globally.
In terms of highest CAGR, the cosmetic surgery segment is expected to grow further and during the forecast period. Increasing continuous adoption of tissue sealants and adhesives for cosmetic surgeries and burn treatment causes the demand to spike. Another cause is the prevalence of breast cancer patients undergoing mastectomy and breast reconstruction procedures. When it comes to end users, hospitals account for the largest share in the market in 2020.
Asia Pacific leading the market
Asia Pacific is expected to grow at the highest CAGR among other regions. The factors contributing to this segment’s growth is the increase in the investment by major players, public health awareness, a growing income per capita, developing medical tourism, less stricter regulations with regard to product manufacturing and distribution, and high public demand foe a better healthcare quality.
Key Market Players
The leading key players in the sealants and adhesives market are: Johnson & Johnson (Ethicon, Inc.) (US), Baxter International, Inc. (US), Becton, Dickinson and Company (US), CryoLife, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Integra Lifesciences Holdings Corporation (US), Medline Industries, Inc. (US), Adhezion Biomedical, LLC (US), Tricol Biomedical, Inc. (US), Vivostat A/S (Denmark), Advanced Medical Solutions Group plc (UK), Stryker Corporation (US), CSL Limited (Australia), Ocular Therapeutix, Inc. (US), MicroVal (France), GEM Srl (Italy), Hemostasis, LLC (US), Péters Surgical (France), and Tissuemed Ltd (UK).
The leading company among all of the other players is Johnson & Johnson since they have a strong and established regional presence. They have the stronger product portfolio for surgical sealants and adhesives. The company has a revenue growth of 5.8% in its biosurgical products segment in 2020.
In a recent development, Johnson & Johnson has launched VISTASEAL Fibrin Sealant for humans to control bleeding surgery. Other key players are also focused on acquiring and expanding their companies by venturing with other emerging markets or collaborations with academic biochemical research and industry.
• Historical data available (as per request)
• Estimation/projections/forecast for revenue and unit sales (2021 – 2028)
• Data breakdown for every market segment (2021 – 2028)
• Gross margin and profitability analysis of companies
• Price analysis of each product type
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategy
Industry Segmentation and Revenue Breakdown
Product Analysis (Revenue, USD Million, 2021 - 2028)
• Natural/Biological Sealants and Adhesives
• Natural/Biological Sealants and Adhesives, By Type
• Polypeptide/protein-based sealants and adhesives
• Fibrin-based sealants and adhesives
• Gelatin-based sealants and adhesives
• Collagen-based sealants and adhesives
• Albumin-based sealants and adhesives
• Polysaccharide-based sealants and adhesives
• Chitosan-based sealants and adhesives
• Other Polysaccharide-based sealants and adhesives
• Natural/Biological Sealants and Adhesives, By Origin
• Human-blood based sealants and adhesives
• Animal-based sealants and adhesives
• Synthetic & Semi-synthetic Sealants and Adhesives
• PEG Hydrogels
• Urethane-based sealants and adhesives
• Other Synthetic & semi-synthetic sealants and adhesives
Indication Analysis (Revenue, USD Million, 2021 - 2028)
• Tissue Sealing
• Surgical Hemostasis
• Tissue Engineering
Application Analysis (Revenue, USD Million, 2021 - 2028)
• Cardiovascular Surgery
• General Surgery
• CNS Surgery
• Orthopedic Surgery
• Cosmetic Surgery
• Urological Surgery
• Pulmonary Surgery
• Ophthalmic Surgery
• Other Applications
End User Analysis (Revenue, USD Million, 2021 - 2028)
• Other End Users
Region Analysis (Revenue, USD Million, 2020 – 2028)
• United States
• United Kingdom
• South Korea
• Saudi Arabia
• Rest of World
• United States Surgical Sealants and Adhesives Industry Research Report
• Europe Surgical Sealants and Adhesives Industry Research Report
• Asia Pacific Surgical Sealants and Adhesives Industry Research Report
Need report on this market for specific region or Country? Or need a customized report as per your need? Want to know discounts as available?
Or Fill the form below "Sample Request Form" with your queries in message box.
Please fill in the form below to Request for free Sample Report
Office Hours Mon - Sat 10:00 - 16:00
Send Us Mail email@example.com
© 2018 Market Decipher. All Rights Reserved